Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

PHASE3UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Coronary Heart Disease
Interventions
DEVICE

Biolimus-eluting stent

The biolimus-eluting coronary stent contains a stainless steel platform on which an abluminally coated polylactic acid (PLA) biodegradable polymer is placed that eludes biolimus-A9.

DEVICE

Everolimus-eluting coronary stent

The everolimus-eluting coronary stent is a cobalt chromium platform stent with a permanent fluorinated copolymer matrix that eludes everolimus

Trial Locations (1)

3076

The Northern Hospital, Epping

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biosensors International

OTHER

lead

Dr Peter Barlis

OTHER